Viewing Study NCT02858206


Ignite Creation Date: 2025-12-26 @ 1:16 PM
Ignite Modification Date: 2026-03-01 @ 8:12 PM
Study NCT ID: NCT02858206
Status: UNKNOWN
Last Update Posted: 2019-07-26
First Post: 2016-07-30
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Simultaneous Integrated Boost Radiotherapy and Concurrent Nimotuzumab or Chemotherapy for Esophageal Carcinoma
Sponsor: Chinese Academy of Medical Sciences
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Esophageal Neoplasms View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Locally advanced esophageal cancer View
None Radiotherapy and nimotuzumab View
None Concurrent chemoradiotherapy View